147 related articles for article (PubMed ID: 15878000)
1. Comparison of C-reactive protein levels before and after coronary stenting and restenosis among patients treated with sirolimus-eluting versus bare metal stents.
Dibra A; Ndrepepa G; Mehilli J; Dirschinger J; Pache J; Schühlen H; Schömig A; Kastrati A
Am J Cardiol; 2005 May; 95(10):1238-40. PubMed ID: 15878000
[TBL] [Abstract][Full Text] [Related]
2. C-Reactive protein, clinical outcome, and restenosis rates after implantation of different drug-eluting stents.
Gaspardone A; Versaci F; Tomai F; Citone C; Proietti I; Gioffrè G; Skossyreva O
Am J Cardiol; 2006 May; 97(9):1311-6. PubMed ID: 16635602
[TBL] [Abstract][Full Text] [Related]
3. Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents.
Mauri L; O'Malley AJ; Popma JJ; Moses JW; Leon MB; Holmes DR; Teirstein PS; Cutlip DE; Donahoe D; Kuntz RE
Am J Cardiol; 2005 May; 95(10):1140-5. PubMed ID: 15877983
[TBL] [Abstract][Full Text] [Related]
4. Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT).
Thuesen L; Kelbaek H; Kløvgaard L; Helqvist S; Jørgensen E; Aljabbari S; Krusell LR; Jensen GV; Bøtker HE; Saunamäki K; Lassen JF; van Weert A;
Am Heart J; 2006 Dec; 152(6):1140-5. PubMed ID: 17161067
[TBL] [Abstract][Full Text] [Related]
5. Comparison of C-reactive protein levels after coronary stenting with bare metal versus sirolimus-eluting stents.
de la Torre-Hernandez JM; Sainz-Laso F; Burgos V; Perez T; Figueroa A; Zueco J; Colman T
Am J Cardiol; 2005 Mar; 95(6):748-51. PubMed ID: 15757602
[TBL] [Abstract][Full Text] [Related]
6. Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels.
Kim JY; Ko YG; Shim CY; Park S; Hwang KC; Choi D; Jang Y; Chung N; Shim WH; Cho SY
Am J Cardiol; 2005 Nov; 96(10):1384-8. PubMed ID: 16275183
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
Stone GW; Moses JW; Ellis SG; Schofer J; Dawkins KD; Morice MC; Colombo A; Schampaert E; Grube E; Kirtane AJ; Cutlip DE; Fahy M; Pocock SJ; Mehran R; Leon MB
N Engl J Med; 2007 Mar; 356(10):998-1008. PubMed ID: 17296824
[TBL] [Abstract][Full Text] [Related]
8. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial.
Valgimigli M; Percoco G; Malagutti P; Campo G; Ferrari F; Barbieri D; Cicchitelli G; McFadden EP; Merlini F; Ansani L; Guardigli G; Bettini A; Parrinello G; Boersma E; Ferrari R;
JAMA; 2005 May; 293(17):2109-17. PubMed ID: 15870414
[TBL] [Abstract][Full Text] [Related]
9. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.
Moussa I; Leon MB; Baim DS; O'Neill WW; Popma JJ; Buchbinder M; Midwall J; Simonton CA; Keim E; Wang P; Kuntz RE; Moses JW
Circulation; 2004 May; 109(19):2273-8. PubMed ID: 15123524
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.
Holmes DR; Teirstein P; Satler L; Sketch M; O'Malley J; Popma JJ; Kuntz RE; Fitzgerald PJ; Wang H; Caramanica E; Cohen SA;
JAMA; 2006 Mar; 295(11):1264-73. PubMed ID: 16531619
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
Windecker S; Remondino A; Eberli FR; Jüni P; Räber L; Wenaweser P; Togni M; Billinger M; Tüller D; Seiler C; Roffi M; Corti R; Sütsch G; Maier W; Lüscher T; Hess OM; Egger M; Meier B
N Engl J Med; 2005 Aug; 353(7):653-62. PubMed ID: 16105989
[TBL] [Abstract][Full Text] [Related]
14. Comparison of late luminal loss response pattern after sirolimus-eluting stent implantation or conventional stenting.
Lemos PA; Mercado N; van Domburg RT; Kuntz RE; O'Neill WW; Serruys PW
Circulation; 2004 Nov; 110(20):3199-205. PubMed ID: 15505082
[TBL] [Abstract][Full Text] [Related]
15. Time course of release of inflammatory markers after coronary stenting: comparison between bare metal stent and sirolimus-eluting stent.
Kefer JM; Galanti LM; Desmet S; Deneys V; Hanet CE
Coron Artery Dis; 2005 Dec; 16(8):505-9. PubMed ID: 16319662
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).
Schofer J; Schlüter M; Gershlick AH; Wijns W; Garcia E; Schampaert E; Breithardt G;
Lancet; 2003 Oct; 362(9390):1093-9. PubMed ID: 14550694
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.
Ardissino D; Cavallini C; Bramucci E; Indolfi C; Marzocchi A; Manari A; Angeloni G; Carosio G; Bonizzoni E; Colusso S; Repetto M; Merlini PA;
JAMA; 2004 Dec; 292(22):2727-34. PubMed ID: 15585732
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis.
Werner GS; Emig U; Krack A; Schwarz G; Figulla HR
Catheter Cardiovasc Interv; 2004 Nov; 63(3):259-64. PubMed ID: 15505841
[TBL] [Abstract][Full Text] [Related]
19. Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents.
Hoffmann R; Stellbrink E; Schröder J; Grawe A; Vogel G; Blindt R; Kelm M; Radke PW
Am J Cardiol; 2007 Nov; 100(9):1347-52. PubMed ID: 17950788
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
Dibra A; Mehilli J; Braun S; Hadamitzky M; Baum H; Dirschinger J; Schühlen H; Schömig A; Kastrati A
Am Heart J; 2005 Aug; 150(2):344-50. PubMed ID: 16086941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
